Farmacosmo Balance Sheet Health
Financial Health criteria checks 5/6
Farmacosmo has a total shareholder equity of €12.6M and total debt of €6.6M, which brings its debt-to-equity ratio to 52%. Its total assets and total liabilities are €33.7M and €21.0M respectively.
Key information
52.0%
Debt to equity ratio
€6.57m
Debt
| Interest coverage ratio | n/a |
| Cash | €4.65m |
| Equity | €12.63m |
| Total liabilities | €21.04m |
| Total assets | €33.68m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: COSMO's short term assets (€20.2M) exceed its short term liabilities (€19.6M).
Long Term Liabilities: COSMO's short term assets (€20.2M) exceed its long term liabilities (€1.4M).
Debt to Equity History and Analysis
Debt Level: COSMO's net debt to equity ratio (15.2%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if COSMO's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable COSMO has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: COSMO is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 33.3% per year.